Partial inhibition of the proteasome enhances the activity of the myelin basic protein promoter

Developmental Neuroscience

Volumn 31, Issue 3, 2009, Pages 169-180

  Calatayud, C A ^a   Garcia C I ^a   Paez, P M ^a   Pasquini, J M ^a   Soto, E F ^a   Pasquini, L A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

MBP promoter; Oligodendroglial cell differentiation; P27Kip1; Proteasome inhibition; Sp1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DNA; MYELIN BASIC PROTEIN; PROTEASOME; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR NKX2.2; TRANSCRIPTION FACTOR SP1;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; ENZYME INHIBITION; GENE ACTIVATION; GENE ACTIVITY; GENE MUTATION; GLIA CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; REPORTER GENE; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P27; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; IMMUNOPRECIPITATION; MICE; MYELIN BASIC PROTEINS; OLIGODENDROGLIA; PROMOTER REGIONS, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASE C; PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 67649126241     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000193393     Document Type: Article

References (24)

1. Pfeiffer SE, Warrington AE, Bansal R: The oligodendrocyte and its many cellular processes. Trends Cell Biol 1993; 3: 191-197.
2. Devine-Beach K, Lashgari MS, Khalili K: Myelin basic protein gene transcription. Identification of proximal and distal cis-acting regulatory elements. J Biol Chem 1990; 265: 13830-13835.
3. Tretiakova A, Steplewski A, Johnson EM, Khalili K, Amini S: Regulation of myelin basic protein gene transcription by Sp1 and Puralpha: evidence for association of Sp1 and Puralpha in brain. J Cell Physiol 1999; 181: 160-168.
4. Tamura T, Miura M, Ikenaka K, Mikoshiba K: Analysis of transcription control elements of the mouse myelin basic protein gene in HeLa cell extracts: demonstration of a strong NFI-binding motif in the upstream region. Nucleic Acids Res 1988; 16: 11441-11459.
5. Wei Q, Miskimins WK, Miskimins R: The Sp1 family of transcription factors is involved in p27Kip1-mediated activation of myelin basic protein gene expression. Mol Cell Biol 2003; 23: 4035-4045.
6. Kip1 . Genes Dev 1997; 11: 2335-2346.
7. Kip1 enhances myelin basic protein gene promoter activity. J Neurosci Res 2002; 67: 100-105.
8. Verity AN, Bredesen D, Vonderscher C, Handley VW, Campagnoni AT: Expression of myelin protein genes and other myelin components in an oligodendrocytic cell line conditionally immortalized with a temperature- sensitive retrovirus. J Neurochem 1993; 60: 577-587.
9. Wrabetz L, Taveggia C, Feltri ML, Quattrin A, Awatramani R, Scherer SS, Messing A, Kamholz J: A minimal human MBP promoter- lacZ transgene is appropriately regulated in developing brain and after optic enucleation, but not in shiverer mutant mice. J Neurobiol 1998; 34: 10-26.
10. Pagano M, Tam SW, Theodora AM, Beer- Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995; 269: 682-685.
11. Su K, Roos MD, Yang X, Han I, Paterson AJ, Kudlow JE: An N-terminal region of Sp1 targets its proteasome- dependent degradation in vitro. J Biol Chem 1999; 274: 15194-15202.
12. Pasquini LA, Paez P, Besio Moreno M, Pasquini JM, Soto EF: Inhibition of the proteasome by lactacystin enhances oligodendroglial cell differentiation. J Neurosci 2003; 23: 4635-4644.
13. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
14. Marta CB, Davio C, Pasquini LA, Soto EF, Pasquini JM: Molecular mechanisms involved in the actions of apotransferrin upon the central nervous system: role of the cytoskeleton and of second messengers. J Neurosci Res 2002; 69: 488-496.
15. Leemhuis J, Boutillier S, Barth H, Feuerstein TJ, Brock C, Nürnberg B, Aktories K, Meyer DK: Rho GTPases and phosphoinositide 3- kinase organize formation of branched dendrites. J Biol Chem 2004; 279: 585-596.
16. Marinovic AC, Zheng B, Mitch WE, Price SR: Ubiquitin (UbC) expression in muscle cells is increased by glucocorticoids through a mechanism involving Sp1 and MEK1. J Biol Chem 2002; 277: 16673-16681.
17. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976; 72: 248- 254.
18. Wei Q, Miskimins WK, Miskimins R: Stagespecific expression of myelin basic protein in oligodendrocytes involves Nkx2.2-mediated repression that is relieved by the Sp1 transcription factor. J Biol Chem 2005; 280: 16284-16294.
19. Mackenzie GG, Carrasquedo F, Delfino JM, Keen CL, Fraga CG, Oteiza PI: Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells. FASEB J 2004; 18: 167-169.
20. Paez PM, García CI, Pasquini JM: Expression of myelin basic protein in two oligodendroglial cell lines is modulated by apotransferrin through different transcription factors. J Neurosci Res 2006; 83: 606-618.
21. Su K, Yang X, Roos MD, Paterson AJ, Kudlow JE: Human Sug1/p45 is involved in the proteasome- dependent degradation of Sp1. Biochem J 2000; 348: 281-289.
22. Santiago-Josefat B, Fernandez-Salguero PM: Proteasome inhibition induces nuclear translocation of the dioxin receptor through an Sp1 and protein kinase C-dependent pathway. J Mol Biol 2003; 333: 249-260.
23. Lu Z, Liu D, Hornia A, Devonish W, Pagano M, Foster DA: Activation of protein kinase C triggers its ubiquitination and degradation. Mol Cell Biol 1998; 18: 839-845.
24. cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep 2001; 2: 27- 34.